Abstract
Tissue engineering is an interdisciplinary field that applies the principles of biology and engineering to developing tissue substitutes to restore, maintain, or improve the function of diseased or damaged human tissues. Autologous mesenchymal stromal cells (MSCs) are good candidates for tissue engineering and regenerative medicine in that they can replace damaged tissues in the human body owing to their self-renewal, plasticity, engraftment, and homing capacity. MSCs can easily differentiate into adipocytes, osteoblasts, and fibroblasts using various transcription factors and hormones. For cell treatments, nanotechnological scaffolds in various structures are needed for differentiation of stem cells. Biodegradable polymeric constructs for bone tissue engineering, are three-dimensional structures that allow bone cells to attach and reproduce on them. Because of biodegradability properties, they are not permanent in the body and are degraded slowly while bone cells are reproducing. Thus, bone cells replace the scaffold in time, which means healing of the defective site.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG (2003) Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 89:1235–1249
Bobis S, Jarocha D, Majka M (2006) Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol 44(4):215–230
Boiret N, Rapatel C, Veyrat-Masson R, Guillouard L, Guérin J-J, Pigeon P, Descamps S, Boisgard S, Berger MG (2005) Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow. Exp Hematol 33:219–225
Cao F-J, Feng S-Q (2009) Human umbilical cord mesenchymal stem cells and the treatment of spinal cord injury. Chin Med J (Engl) 122(2):225–231
Caplan AI (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213(2):341–347
Carlo-Stella C, Gianni MA (2005) Biology and clinical applications of marrow mesenchymal stem cells. Pathol Biol 53:162–164
Choppes RP et al (2009) Stem cell therapy to reduce radiation-induced normal tissue damage. Semin Radiat Oncol 19:112–121
Cognet PA, Minguell JJ (1999) Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181:67–73
Corsten MF et al (2008) Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare. Lancet Oncol 9:376–384
Dennis JE, Carbillet JP, Caplan AI, Charbord P (2002) The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs 170:73–82
Devine SM, Hoffman R (2000) Role of mesenchymal stemcell in hematopoietic stem cell transplantation. Curr Opin Hematol 7:358–363
Dwyer RM et al (2007) Monocyte chemotactic proteion-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res 13(17):5020–5027
Greenberg JS et al (2009) Bone marrow-derived stem cells and radiation response. Semin Radiat Oncol 19:133–139
Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM (2001) Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 189:54–63
Gronthos S, Zannettino AC, Hay DJ, Shi S, Graves SE, Kortesidis A, Simmonos PJ (2003) Molecular and cellular characterization of highly purified stromal stems derived from human bone marrow. J Cell Sci 116:1827–1835
Igura K, Zhang X, Takahashi K, Mitsuru A, Yamaguchi S, Takashi TA (2004) Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy 6:543–553
Jorgensen C et al (2009) Link between cancer stem cells and adult mesenchymal stromal cells: implications for cancer therapy. Regen Med 4(2):149–152
Kidd S et al (2008) The auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy 10(7):657–667
Klingemann H et al (2008) Mesenchymal stem cells: sources and clinical applications. Transfus Med Hemother 35:272–277
Koç ON et al (2002) Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30:215–222
Kucerova L, Altanerova V, Matuskova M, Tyciakova S, Altaner C (2007) Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 67(13): 6304–6313
Lazennec G et al (2008) Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem Cells 26(6):1387–1394
Lee K-D (2005) Mesenchymal stem cells. Chang Gung Med J 31(3):228–235
Miura M, Gronthos S, Zhao M, Lu B, Fisher LW, Robey PG, Shi S (2003) SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA 100:5807–5812
Neuenschwander S, Hoerstrup SP (2004) Organogenesis and tissue engineering in transplantation medicine. Transpl Immunol 12(3–4):359–365
Nishida K (2003) Tissue engineering of the cornea. Cornea 22:S28–S34
Ozawa K et al (2008) Cell and gene therapy using mesenchymal stem cells (MSCs). J Autoimmun 30:121–127
Patel SA, Sherman L, Munoz J, Rameshwar P (2008a) Immunological properties of mesenchymal stem cells and clinical implications. Arch Immunol Ther Exp 56:1–8
Patel SA et al (2008b) Immunological properties of mesenchymal stem cells and clinical implications. Arch Immunol Ther Exp (Warsz) 56:1–8
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simoneti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
Studeny M et al (2004) Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96(21):1593–1603
Sacks MS, Schoen FJ, Mayer JE (2009) Bioengineering challenges for heart valve tissue engineering. Ann Rev Biomed Eng 11:289–313
Tsai MS, Lee JL, Chang YJ, Hwang SM (2004) Isolation of human multipotent mesenchymal stem cells from second trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 19:1450–1456
Wang HS et al (2004) Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord blood. Stem Cells 22:1330–1337
Woodward WA et al (2009) Radiosensitivity of cancer-initiated cells and normal stem cells (or what the Heisenberg uncertainly principle has to do with biology). Semin Radiat Oncol 19:87–95
Zielske SP et al (2009) Radiation increases invasion of gene-modified mesenchymal stem cells into tumors. Int J Radiat Oncol Biol Phys 75(3):843–853
Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA, Maini RN (2000) Mesenchymal precursor, cells in the blood of normal individuals. Arthritis Res 2:477–488
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Yurtsever, A. (2012). Tissue Engineering Based on the Importance of Collaboration Between Clinicians and Basic Scientists Regarding Mesenchymal Stromal Cells. In: Turksen, K. (eds) Adult and Embryonic Stem Cells. Stem Cell Biology and Regenerative Medicine. Humana Press. https://doi.org/10.1007/978-1-61779-630-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-61779-630-2_7
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-629-6
Online ISBN: 978-1-61779-630-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)